Ozempic's retail list price is approximately $935/month. With Novo Nordisk's NovoCare savings card, commercially insured patients may pay as little as $25/month. Cash-pay uninsured patients can access it for ~$99/month through the NovoCare patient assistance program, or $850–$950 via GoodRx.
Wegovy's list price is ~$1,349/month. With the Novo Nordisk savings card, commercially insured patients may pay $0–$200/month. Uninsured patients pay approximately $499/month through Novo's patient assistance program. Telehealth subscriptions typically bundle the medication for $299–$499/month.
Mounjaro's list price is ~$1,069/month. Eli Lilly's savings card brings the cost to $25/month for commercially insured patients. Without insurance, expect to pay $550+/month or find telehealth programs ranging from $299–$499/month that include the medication.
Zepbound's list price is ~$1,059/month. Like Mounjaro, Eli Lilly's savings card caps costs at $25/month for commercially insured patients. For those without commercial insurance, costs range from $550+/month at retail to $200–$450/month at compounding pharmacies.
Novo Nordisk offers savings cards (formerly called "savings programs") for Ozempic and Wegovy through their websites (novocare.com). Eligibility typically requires commercial insurance that covers the drug, though limited uninsured programs are also available. You must not be enrolled in Medicare, Medicaid, or any federal/state healthcare program.
Medicare Part D covers Ozempic and Mounjaro when prescribed for type 2 diabetes. However, Medicare does NOT generally cover GLP-1s for weight loss alone due to a statutory exclusion. Notable exception: Zepbound gained Medicare coverage approval for obstructive sleep apnea (OSA) in 2024. Cost varies by plan, but Part D beneficiaries have out-of-pocket caps of $2,000/year starting in 2025.
Medicaid coverage varies by state. Most states cover GLP-1s for type 2 diabetes. Coverage for obesity/weight management is less consistent — some states have expanded coverage, while others have strict prior authorization requirements or exclude weight loss drugs entirely. Contact your state's Medicaid program for current coverage details.
Yes, GoodRx coupons can be used at most major pharmacy chains for GLP-1 medications. However, you cannot use GoodRx simultaneously with insurance. GoodRx prices are generally close to retail cash prices (~$850–$1,350/month depending on the drug) and are typically higher than manufacturer savings cards for commercially insured patients.
Telehealth programs (Ro, Hims/Hers, Found, Henry Meds, etc.) offer monthly subscription plans that bundle the GLP-1 medication with provider visits and ongoing care. Pricing typically ranges from $199–$499/month depending on the drug and provider. These programs often use compounded medications or have partnerships to provide brand medications at lower costs than retail.
Yes, if your GLP-1 is prescribed for a qualifying medical condition (type 2 diabetes, obesity with comorbidity, etc.), you can pay for it with pre-tax HSA or FSA dollars. This effectively reduces your cost by your marginal tax rate — for example, if you pay 22% federal income tax, a $500 monthly cost becomes an effective $390/month in after-tax dollars.
Sources & Methodology
[1]Ozempic (semaglutide) prescribing information. Novo Nordisk, 2023. FDA Label
[2]Wegovy (semaglutide) U.S. pricing. NovoCare.com patient assistance program, accessed May 2026.